Biomarker qualification is the process by which a biomarker is rigorously evaluated and accepted for a specific context of use in drug development and regulatory decision-making. This ensures that the biomarker is reliable, reproducible, and relevant for its intended purpose, ultimately aiding in drug development and patient care.